Publicaciones en colaboración con investigadores/as de Mutua de Terrassa (9)

2024

  1. Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia

    Movement Disorders

  2. Genome sequence analyses identify novel risk loci for multiple system atrophy

    Neuron, Vol. 112, Núm. 13, pp. 2142-2156.e5

  3. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

    American Journal of Human Genetics, Vol. 111, Núm. 7, pp. 1316-1329

  4. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

2023

  1. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinson's Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)

    npj Parkinson's Disease

  2. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)

    npj Parkinson's Disease, Vol. 9, Núm. 1

  3. Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson’s disease

    npj Parkinson's Disease, Vol. 9, Núm. 1

2022

  1. Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach

    Journal of Alzheimer's Disease, Vol. 89, Núm. 1, pp. 193-207

2019

  1. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

    Alzheimer's and Dementia, Vol. 15, Núm. 10, pp. 1333-1347